Latest period
$61.34B
YoY change
+19.2%
5Y CAGR
+10.5%
Peak year (2025)
$56.81B
Latest annual
$56.81B
Total Liabilities history chart for Thermo Fisher Scientific (TMO) from 1985 to 2025
Latest: $56.81B
Total Liabilities growth chart for Thermo Fisher Scientific (TMO) from 1985 to 2025
Latest: +19.2%
Total Liabilities history table for Thermo Fisher Scientific (TMO) from 1985 to 2025
| 2025 | $56.81B | +19.2% | +$9.16B | ||
| 2024 | $47.65B | -8.2% | −$4.23B | ||
| 2023 | $51.88B | -2.1% | −$1.12B | ||
| 2022 | $53.01B | -2.1% | −$1.14B | ||
| 2021 | $54.15B | +56.8% | +$19.61B | ||
| 2020 | $34.53B | +20.3% | +$5.83B | ||
| 2019 | $28.71B | +0.2% | +$60.00M | ||
| 2018 | $28.65B | -8.4% | −$2.61B | ||
| 2017 | $31.26B | +28.3% | +$6.89B | ||
| 2016 | $24.37B | +25.1% | +$4.88B | ||
| 2015 | $19.48B | -12.6% | −$2.82B | ||
| 2014 | $22.30B | +48.6% | +$7.30B | ||
| 2013 | $15.01B | +25.3% | +$3.03B | ||
| 2012 | $11.98B | +1.6% | +$184.30M | ||
| 2011 | $11.80B | +95.8% | +$5.77B | ||
| 2010 | $6.03B | -2.3% | −$144.10M | ||
| 2009 | $6.17B | +0.1% | +$6.50M | ||
| 2008 | $6.16B | -8.3% | −$555.70M | ||
| 2007 | $6.72B | -8.6% | −$631.31M | ||
| 2006 | $7.35B | +404.1% | +$5.89B | ||
| 2005 | $1.46B | +60.0% | +$547.08M | ||
| 2004 | $911.17M | -9.4% | −$94.99M | ||
| 2003 | $1.01B | -37.7% | −$607.58M | ||
| 2002 | $1.61B | -15.5% | −$296.29M | ||
| 2001 | $1.91B | -17.1% | −$394.24M | ||
| 2000 | $2.30B | -17.6% | −$491.04M | ||
| 1999 | $2.80B | -16.3% | −$544.50M | ||
| 1998 | $3.34B | +11.9% | +$354.70M | ||
| 1997 | $2.99B | +13.7% | +$358.90M | ||
| 1996 | $2.63B | +34.3% | +$670.30M | ||
| 1995 | $1.96B | +14.9% | +$254.00M | ||
| 1994 | $1.70B | +28.6% | +$378.90M | ||
| 1993 | $1.32B | +20.8% | +$227.40M | ||
| 1992 | $1.10B | +85.5% | +$505.10M | ||
| 1991 | $590.50M | +18.5% | +$92.10M | ||
| 1990 | $498.40M | +37.9% | +$137.00M | ||
| 1989 | $361.40M | +17.1% | +$52.80M | ||
| 1988 | $308.60M | +16.8% | +$44.30M | ||
| 1987 | $264.30M | +62.0% | +$101.20M | ||
| 1986 | $163.10M | +35.8% | +$43.00M | ||
| 1985 | $120.10M | — | — |
- 2025$56.81B+19.2%
- 2024$47.65B-8.2%
- 2023$51.88B-2.1%
- 2022$53.01B-2.1%
- 2021$54.15B+56.8%
- 2020$34.53B+20.3%
- 2019$28.71B+0.2%
- 2018$28.65B-8.4%
- 2017$31.26B+28.3%
- 2016$24.37B+25.1%
- 2015$19.48B-12.6%
- 2014$22.30B+48.6%
- 2013$15.01B+25.3%
- 2012$11.98B+1.6%
- 2011$11.80B+95.8%
- 2010$6.03B-2.3%
- 2009$6.17B+0.1%
- 2008$6.16B-8.3%
- 2007$6.72B-8.6%
- 2006$7.35B+404.1%
- 2005$1.46B+60.0%
- 2004$911.17M-9.4%
- 2003$1.01B-37.7%
- 2002$1.61B-15.5%
- 2001$1.91B-17.1%
- 2000$2.30B-17.6%
- 1999$2.80B-16.3%
- 1998$3.34B+11.9%
- 1997$2.99B+13.7%
- 1996$2.63B+34.3%
- 1995$1.96B+14.9%
- 1994$1.70B+28.6%
- 1993$1.32B+20.8%
- 1992$1.10B+85.5%
- 1991$590.50M+18.5%
- 1990$498.40M+37.9%
- 1989$361.40M+17.1%
- 1988$308.60M+16.8%
- 1987$264.30M+62.0%
- 1986$163.10M+35.8%
- 1985$120.10M—
Total Liabilities values are taken from Thermo Fisher Scientific's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Liabilities at Thermo Fisher Scientific (TMO)
According to Thermo Fisher Scientific's latest reported financial statements, the company's latest reported total liabilities is $61.34B. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and total equity for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Thermo Fisher Scientific (TMO) reported total liabilities of $56.81B – grew 19.2% year-over-year.
Over 2020–2025 (5 years), Thermo Fisher Scientific total liabilities expanded at a +10.5% compound annual rate, with mixed annual results across the window.
$56.81B stands as the all-time-high annual total liabilities, posted in 2025, against a low of $120.10M during 1985.
Thermo Fisher Scientific Total Liabilities by Year
Thermo Fisher Scientific Total Liabilities 2025: $56.81B
Thermo Fisher Scientific total liabilities in 2025 was $56.81B, grew 19.2% from 2024. This figure represents the highest annual value in the available history.
Thermo Fisher Scientific Total Liabilities 2024: $47.65B
2024's total liabilities for Thermo Fisher Scientific came in at $47.65B, declined 8.2% below 2023.
Thermo Fisher Scientific Total Liabilities 2023: $51.88B
Thermo Fisher Scientific posted total liabilities of $51.88B in 2023, edged down 2.1% below 2022.
Thermo Fisher Scientific Total Liabilities 2022: $53.01B
In 2022, Thermo Fisher Scientific reported total liabilities of $53.01B, edged down 2.1% below 2021.
Thermo Fisher Scientific Total Liabilities 2021: $54.15B
Thermo Fisher Scientific total liabilities in 2021 was $54.15B.
See more financial history for Thermo Fisher Scientific (TMO).
Sector peers by Total Liabilities
Healthcare peers of Thermo Fisher Scientific (TMO), ranked by their latest total liabilities
| $207.88B | |
| $137.19B | |
| $117.67B | |
| $85.94B | |
| $84.20B | |
| $81.93B | |
| $65.36B | |
| $54.86B |
- $207.88B
- $137.19B
- $117.67B
- $85.94B
- $84.20B
- $81.93B
- $65.36B
- $54.86B
Frequently asked questions
Thermo Fisher Scientific (TMO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation